Abstract
The significant physiologic adaptations of pregnancy predispose to arrhythmias, while concurrent changes in pharmacokinetics and concerns for fetal health and well-being complicate management. An increased incidence of both atrial and ventricular arrhythmias has been reported in population-based Holter studies, yet most incident pregnancy-related arrhythmias are benign and do not require intervention. Pharmacologic absorption, distribution, metabolism, and elimination are altered, as are gut absorption, protein binding, and hepatic and renal blood flow. This chapter will review antiarrhythmic drug therapy by Vaughn Williams classification, nonpharmacologic arrhythmia therapy (cardiovascular implanted electronic devices and ablation), as well as management of specific cardiovascular conditions during pregnancy, labor, and postpartum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gordon MC (2007) Chapter 3 – maternal physiology. In: Obstetrics: normal and problem pregnancies, 5th edn. Churchill Livingstone, an imprint of Elsevier, Philadelphia
Theunissen IM, Parer JT (1994) Fluid and electrolytes in pregnancy. Clin Obstet Gynecol 37(1):3–15
Lindheimer MD, Davison JM (1995) Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol 132(2):133–143
Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H (1988) Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancies. Am J Obstet Gynecol 158(2):393–399
Duvekot JJ, Peeters LL (1994) Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 49(12 Suppl):S1–S14
van Oppen AC, Stigter RH, Bruinse HW (1996) Cardiac output in normal pregnancy: a critical review. Obstet Gynecol 87(2):310–318
Hunter S, Robson SC (1992) Adaptation of the maternal heart in pregnancy. Br Heart J 68(6):540–543
Clark SL, Cotton DB, Pivarnik JM et al (1991) Position change and central hemodynamic profile during normal third-trimester pregnancy and post partum. Am J Obstet Gynecol 164(3):883–887
Clapp JF 3rd, Seaward BL, Sleamaker RH, Hiser J (1988) Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol 159(6):1456–1460
Granger JP (2002) Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology. Am J Physiol Regul Integr Comp Physiol 283(6):R1289–R1292
Kametas NA, McAuliffe F, Hancock J, Chambers J, Nicolaides KH (2001) Maternal left ventricular mass and diastolic function during pregnancy. Ultrasound Obstet Gynecol 18(5):460–466
Zentner D, du Plessis M, Brennecke S, Wong J, Grigg L, Harrap SB (2009) Deterioration in cardiac systolic and diastolic function late in normal human pregnancy. Clin Sci (Lond) 116(7):599–606
Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79(8):1061–1064
Li JM, Nguyen C, Joglar JA, Hamdan MH, Page RL (2008) Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol 31(11):538–541
Joglar JA, Page RL (1999) Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 20(1):85–94
Walbrandt-Pigarelli DL, Kraus CK, Potter BE (2008) Chapter 81. Pregnancy and lactation: therapeutic considerations. In: Pharmacotherapy: a pathophysiologic approach, 7th edn. McGraw-Hill
Hebert MF, Easterling TR, Kirby B et al (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84(2):248–253
Hebert MF, Carr DB, Anderson GD et al (2005) Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 45(1):25–33
Elkayam U, Goodwin TM (1995) Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 75(7):521–523
Hagley MT, Cole PL (1994) Adenosine use in pregnant women with supraventricular tachycardia. Ann Pharmacother 28(11):1241–1242
Joglar JA, Page RL (2001) Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 16(1):40–45
Page RL (1995) Treatment of arrhythmias during pregnancy. Am Heart J 130(4):871–876
Warnes CA (2007) Chapter 77 – pregnancy and heart disease. In: Braunwald’s heart disease: a textbook of cardiovascular medicine, 8th edn. Philadelphia
Rogers MC, Willerson JT, Goldblatt A, Smith TW (1972) Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med 287(20):1010–1013
Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44(10):989–1008
Lees KR, Rubin PC (1987) Treatment of cardiovascular diseases. Br Med J (Clin Res Ed) 294(6568):358–360
Chan V, Tse TF, Wong V (1978) Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol 85(8):605–609
Wong RD, Murthy AR, Mathisen GE, Glover N, Thornton PJ (1992) Treatment of severe falciparum malaria during pregnancy with quinidine and exchange transfusion. Am J Med 92(5):561–562
Hill LM, Malkasian GD Jr (1979) The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 54(3): 366–368
Meyer J, Lackner J, Schochet S (1930) Paroxysmal tachycardia in pregnancy. JAMA 94:1901–1904
Allen NM, Page RL (1993) Procainamide administration during pregnancy. Clin Pharm 12(1):58–60
Wilson JT, Brown RD, Cherek DR et al (1980) Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet. 5(1):1–66
Shaxted EJ, Milton PJ (1979) Disopyramide in pregnancy: a case report. Curr Med Res Opin 6(1):70–72
Leonard RF, Braun TE, Levy AM (1978) Initiation of uterine contractions by disopyramide during pregnancy. N Engl J Med 299(2):84–85
Tadmor OP, Keren A, Rosenak D et al (1990) The effect of disopyramide on uterine contractions during pregnancy. Am J Obstet Gynecol 162(2):482–486
Abbi M, Kriplani A, Singh B (1999) Preterm labor and accidental hemorrhage after disopyramide therapy in pregnancy. A case report. J Reprod Med 44(7):653–655
Brown WU, Bell GC, Lurie AO, Weiss B, Scanlon JW, Alper MH (1975) Newborn blood levels of lidocaine and mepivacaine in the first postnatal day following maternal epidural anesthesia. Anesthesiology 42(6):698–707
De Praeter C, Vanhaesebrouck P, De Praeter N, Govaert P, Bogaert M, Leroy J (1991) Episiotomy and neonatal lidocaine intoxication. Eur J Pediatr 150(9):685–686
Kim WY, Pomerance JJ, Miller AA (1979) Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics 64(5):643–645
Shnider SM, Way EL (1968) Plasma levels of lidocaine (Xylocaine) in mother and newborn following obstetrical conduction anesthesia: clinical applications. Anesthesiology 29(5):951–958
Brown WU Jr, Bell GC, Alper MH (1976) Acidosis, local anesthetics, and the newborn. Obstet Gynecol 48(1):27–30
Gregg AR, Tomich PG (1988) Mexilitene use in pregnancy. J Perinatol 8(1):33–35
Lownes HE, Ives TJ (1987) Mexiletine use in pregnancy and lactation. Am J Obstet Gynecol 157(2):446–447
Timmis AD, Jackson G, Holt DW (1980) Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet 2(8195 Pt 1):647–648
Villanova C, Muriago M, Nava F (1998) Arrhythmogenic right ventricular dysplasia: pregnancy under flecainide treatment. G Ital Cardiol 28(6):691–693
Ahmed K, Issawi I, Peddireddy R (1996) Use of flecainide for refractory atrial tachycardia of pregnancy. Am J Crit Care 5(4):306–308
Connaughton M, Jenkins BS (1994) Successful use of flecainide to treat new onset maternal ventricular tachycardia in pregnancy. Br Heart J 72(3):297
Doig JC, McComb JM, Reid DS (1992) Incessant atrial tachycardia accelerated by pregnancy. Br Heart J 67(3): 266–268
Gerli S, Clerici G, Mattei A, Di Renzo GC (2006) Flecainide treatment of fetal tachycardia and hydrops fetalis in a twin pregnancy. Ultrasound Obstet Gynecol 28(1):117
Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K (1991) Flecainide in the treatment of fetal tachycardias. Br Heart J 65(1):46–48
Wagner X, Jouglard J, Moulin M, Miller AM, Petitjean J, Pisapia A (1990) Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 119(3 Pt 1):700–702
Braverman AC, Bromley BS, Rutherford JD (1991) New onset ventricular tachycardia during pregnancy. Int J Cardiol 33(3):409–412
Libardoni M, Piovan D, Busato E, Padrini R (1991) Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk. Br J Clin Pharmacol 32(4):527–528
Frishman WH, Chesner M (1988) Beta-adrenergic blockers in pregnancy. Am Heart J 115(1 Pt 1):147–152
Lydakis C, Lip GY, Beevers M, Beevers DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12(6):541–547
Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG (1997) Effect of atenolol on birth weight. Am J Cardiol 79(10):1436–1438
Beardmore KS, Morris JM, Gallery ED (2002) Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 21(1):85–95
Lindeberg S, Sandstrom B, Lundborg P, Regardh CG (1984) Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate. Acta Obstet Gynecol Scand Suppl 118:61–64
O’Hare MF, Leahey W, Murnaghan GA, McDevitt DG (1983) Pharmacokinetics of sotalol during pregnancy. Eur J Clin Pharmacol 24(4):521–524
O’Hare MF, Murnaghan GA, Russell CJ, Leahey WJ, Varma MP, McDevitt DG (1980) Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol 87(9):814–820
O’Hare MF, Russell CJ, Leahey WJ, Varma MP, Murnaghan GA, McDevitt DG (1979) Sotalol in the management of hypertension complicating pregnancy [proceedings]. Br J Clin Pharmacol 8(4):390P–391P
Danielsson BR, Skold AC, Azarbayjani F (2001) Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Curr Pharm Des 7(9):787–802
Webster WS, Brown-Woodman PD, Snow MD, Danielsson BR (1996) Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity. Teratology 53(3):168–175
Burkart TA, Kron J, Miles WM, Conti JB, Gonzalez MD (2007) Successful termination of atrial flutter by ibutilide during pregnancy. Pacing Clin Electrophysiol 30(2):283–286
Kockova R, Kocka V, Kiernan T, Fahy GJ (2007) Ibutilide-induced cardioversion of atrial fibrillation during pregnancy. J Cardiovasc Electrophysiol 18(5):545–547
Marks TA, Terry RD (1996) Developmental toxicity of ibutilide fumarate in rats after oral administration. Teratology 54(3):157–164
McKenna WJ, Harris L, Rowland E, Whitelaw A, Storey G, Holt D (1983) Amiodarone therapy during pregnancy. Am J Cardiol 51(7):1231–1233
Robson DJ, Jeeva Raj MV, Storey GC, Holt DW (1985) Use of amiodarone during pregnancy. Postgrad Med J 61: 75–77
Foster CJ, Love HG (1988) Amiodarone in pregnancy. Case report and review of the literature. Int J Cardiol 20(3): 307–316
Strunge P, Frandsen J, Andreasen F (1988) Amiodarone during pregnancy. Eur Heart J 9(1):106–109
Plomp TA, Vulsma T, de Vijlder JJ (1992) Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol 43(3):201–207
Valensise H, Civitella C, Garzetti GG, Romanini C (1992) Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. Prenat Diagn 12(9): 705–708
Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G (1995) Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 172(4 Pt 1):1307–1311
Bartalena L, Bogazzi F, Braverman LE, Martino E (2001) Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24(2):116–130
Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U (1991) Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 122(4 Pt 1):1162–1166
Pitcher D, Leather HM, Storey GC, Holt DW (1983) Amiodarone in pregnancy. Lancet 1(8324):597–598
Tan HL, Lie KI (2001) Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22(6):458–464
Byerly WG, Hartmann A, Foster DE, Tannenbaum AK (1991) Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med 20(5):552–554
Cleary-Goldman J, Salva CR, Infeld JI, Robinson JN (2003) Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy. J Matern Fetal Neonatal Med 14(2):132–135
Rey E, Duperron L, Gauthier R, Lemay M, Grignon A, LeLorier J (1985) Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. Am J Obstet Gynecol 153(3):311–312
Rimar JM (1985) Verapamil for fetal supraventricular tachycardia. MCN Am J Matern Child Nurs 10(5):345
Klein V, Repke JT (1984) Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstet Gynecol 63(3 Suppl):16S–18S
Owen J, Colvin EV, Davis RO (1988) Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol 158(5):1169–1170
Truccone N, Mariona F (1985) Intrauterine conversion of fetal supraventricular tachycardia with combination of digoxin and verapamil. Pediatr Pharmacol (New York) 5(2):149–153
Lilja H, Karlsson K, Lindecrantz K, Sabel KG (1984) Treatment of intrauterine supraventricular tachycardia with digoxin and verapamil. J Perinat Med 12(3):151–154
Lubbe WF (1987) Use of diltiazem during pregnancy. N Z Med J 100(818):121
Khandelwal M, Kumanova M, Gaughan JP, Reece EA (2002) Role of diltiazem in pregnant women with chronic renal disease. J Matern Fetal Neonatal Med 12(6):408–412
Cullhed I (1983) Cardioversion during pregnancy. A case report. Acta Med Scand 214(2):169–172
Finlay AY, Edmunds V (1979) D.C. cardioversion in pregnancy. Br J Clin Pract 33(3):88–94
Klepper I (1981) Cardioversion in late pregnancy. The anaesthetic management of a case of Wolff-Parkinson-White syndrome. Anaesthesia 36(6):611–616
Ogburn PL Jr, Schmidt G, Linman J, Cefalo RC (1982) Paroxysmal tachycardia and cardioversion during pregnancy. J Reprod Med 27(6):359–362
Schroeder JS, Harrison DC (1971) Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol 27(4):445–446
Rosemond RL (1993) Cardioversion during pregnancy. JAMA 269(24):3167
Barnes EJ, Eben F, Patterson D (2002) Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. BJOG 109(12):1406–1407
Atta E, Gardner M (2007) Cardiopulmonary resuscitation in pregnancy. Obstet Gynecol Clin North Am 34(3):585–597
Morris S, Stacey M (2003) Resuscitation in pregnancy. BMJ 327(7426):1277–1279
Mallampalli A, Guy E (2005) Cardiac arrest in pregnancy and somatic support after brain death. Crit Care Med 33(10 Suppl):S325–331
Part 10.8: Cardiac Arrest Associated With Pregnancy. Circulation. December 13, 2005; 112 (24_suppl):IV-150–IV-153
Goodwin AP, Pearce AJ (1992)The human wedge. A manoeuvre to relieve aortocaval compression during resuscitation in late pregnancy. Anaesthesia 47(5):433–434
Nanson J, Elcock D, Williams M, Deakin CD (2001) Do physiological changes in pregnancy change defibrillation energy requirements? Br J Anaesth 87(2):237–239
Suri V, Keepanasseril A, Aggarwal N, Vijayvergiya R, Chopra S, Rohilla M (2009) Maternal complete heart block in pregnancy: analysis of four cases and review of management. J Obstet Gynaecol Res 35(3):434–437
Minassian VA, Jazayeri A (2002) Favorable outcome in a pregnancy with complete fetal heart block and severe bradycardia. Obstet Gynecol 100(5 Pt 2):1087–1089
Dalvi BV, Chaudhuri A, Kulkarni HL, Kale PA (1992) Therapeutic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol 79(5 Pt 2):802–804
Bemiller CR, Forker AD, Morgan JR (1970) Complete heart block, prosthetic aortic valve, and successful pregnancy. JAMA 214(5):915
Ginns HM, Hollinrake K (1970) Complete heart block in pregnancy treated with an internal cardiac pacemaker. J Obstet Gynaecol Br Commonw 77(8):710–712
Schonbrun M, Rowland W, Quiroz AC (1966) Complete heart block in pregnancy. Successful use of an intravenous pacemaker in 2 patients during labor. Obstet Gynecol 27(2):243–246
Middleton EB, Lee YC (1971) Pregnancy associated with cardiac pacemaker generator implanted in abdominal wall. A case report. Obstet Gynecol 38(2):272–275
Bilge M, Guler N, Eryonucu B (1999) Recurrent pulmonary emboli and thrombus attached to a permanently implanted pacemaker wire in pregnancy. Acta Cardiol 54(2):97–99
Sharma JB, Malhotra M, Pundir P (2000) Successful pregnancy outcome with cardiac pacemaker after complete heart block. Int J Gynaecol Obstet 68(2):145–146
Pedrinazzi C, Gazzaniga P, Durin O, Tovena D, Inama G (2008) Implantation of a permanent pacemaker in a pregnant woman under the guidance of electrophysiologic signals and transthoracic echocardiography. J Cardiovasc Med (Hagerstown) 9(11):1169–1172
Antonelli D, Bloch L, Rosenfeld T (1999) Implantation of permanent dual chamber pacemaker in a pregnant woman by transesophageal echocardiographic guidance. Pacing Clin Electrophysiol 22(3):534–535
Gudal M, Kervancioglu C, Oral D, Gurel T, Erol C, Sonel A (1987) Permanent pacemaker implantation in a pregnant woman with the guidance of ECG and two-dimensional echocardiography. Pacing Clin Electrophysiol 10(3 Pt 1): 543–545
Piper JM, Berkus M, Ridgway LE 3rd (1992) Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator. Am J Obstet Gynecol 167(2):506–507
Isaacs JD, Mulholland DH, Hess LW, Allbert JR, Martin RW (1993) Pregnancy in a woman with an automatic implantable cardioverter-defibrillator. A case report. J Reprod Med 38(6):487–488
Bonini W, Botto GL, Broffoni T, Dondina C (2000) Pregnancy with an ICD and a documented ICD discharge. Europace 2(1):87–90
Olufolabi AJ, Charlton GA, Allen SA, Mettam IM, Roberts PR (2002) Use of implantable cardioverter defibrillator and anti-arrhythmic agents in a parturient. Br J Anaesth 89(4):652–655
Abello M, Peinado R, Merino JL et al (2003) Cardioverter defibrillator implantation in a pregnant woman guided with transesophageal echocardiography. Pacing Clin Electrophysiol 26(9):1913–1914
Doyle NM, Monga M, Montgomery B, Dougherty AH (2005) Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Fetal Neonatal Med 18(2):141–144
Natale A, Davidson T, Geiger MJ, Newby K (1997) Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation 96(9):2808–2812
Bongiorni MG, Di Cori A, Soldati E et al (2008) Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy. Europace 10(8):1018–1021
Kanjwal Y, Kosinski D, Kanj M, Thomas W, Grubb B (2005) Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy. J Interv Card Electrophysiol 13(3):239–242
Pagad SV, Barmade AB, Toal SC, Vora AM, Lokhandwala YY (2004) ‘Rescue’ radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy. Indian Heart J 56(3):245–247
Bombelli F, Lagona F, Salvati A, Catalfamo L, Ferrari AG, Pappone C (2003) Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy. Obstet Gynecol 102(5 Pt 2):1171–1173
Dominguez A, Iturralde P, Hermosillo AG, Colin L, Kershenovich S, Garrido LM (1999) Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing Clin Electrophysiol 22(1 Pt 1):131–134
Gleicher N, Meller J, Sandler RZ, Sullum S (1981) Wolff-Parkinson-White syndrome in pregnancy. Obstet Gynecol 58(6):748–752
Kounis NG, Zavras GM, Papadaki PJ, Soufras GD, Kitrou MP, Poulos EA (1995) Pregnancy-induced increase of supraventricular arrhythmias in Wolff-Parkinson-White syndrome. Clin Cardiol 18(3):137–140
Schwartz PJ, Priori SG, Spazzolini C et al (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103(1):89–95
Rashba EJ, Zareba W, Moss AJ et al (1998) Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS investigators. Circulation 97(5):451–456
Seth R, Moss AJ, McNitt S et al (2007) Long QT syndrome and pregnancy. J Am Coll Cardiol 49(10):1092–1098
Thaman R, Varnava A, Hamid MS et al (2003) Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 89(7):752–756
Pelliccia F, Cianfrocca C, Gaudio C, Reale A (1992) Sudden death during pregnancy in hypertrophic cardiomyopathy. Eur Heart J 13(3):421–423
Autore C, Conte MR, Piccininno M et al (2002) Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40(10):1864–1869
Proceedings of the 32ND Bethesda Conference (2001) Care of the adult with congenital heart disease. J Am College Cardiol 37:1161–1198
Siu SC, Sermer M, Harrison DA et al (1997) Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96(9):2789–2794
Siu SC, Sermer M, Colman JM et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104(5):515–521
Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC (2006) Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 97(8):1206–1212
Tateno S, Niwa K, Nakazawa M, Akagi T, Shinohara T, Yasuda T (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy: multicenter study. Circ J 67(12):992–997
Niwa K, Tateno S, Akagi T et al (2007) Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int J Cardiol 122(2):143–148
Drenthen W, Pieper PG, Ploeg M et al (2005) Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 26(23):2588–2595
Megerian G, Bell JG, Huhta JC, Bottalico JN, Weiner S (1994) Pregnancy outcome following Mustard procedure for transposition of the great arteries: a report of five cases and review of the literature. Obstet Gynecol 83(4):512–516
Meijer JM, Pieper PG, Drenthen W et al (2005) Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 91(6):801–805
Gibson PS, Powrie R, Pipert J (2001) Prevalence of syncope and recurrent presyncope during pregnancy. Obstet Gynecol Surv 97:S41–S42
Goland S, Elkayam U (2009) Cardiovascular problems in pregnant women with marfan syndrome. Circulation 119(4):619–623
Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ (2005) Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 26(9):914–920
Yetman AT, Bornemeier RA, McCrindle BW (2003) Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 41(2):329–332
Berlinerblau R, Yessian A, Lichstein E, Haberman S, Oruci E, Jewelewicz R (2001) Maternal arrhythmias of normal labor and delivery. Gynecol Obstet Invest 52(2):128–131
Romem A, Romem Y, Katz M, Battler A (2004) Incidence and characteristics of maternal cardiac arrhythmias during labor. Am J Cardiol 93(7):931–933
Anderson GD (2006) Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation. Expert Opin Drug Metab Toxicol 2(6):947–960
American Academy of Pediatrics Committee on Drugs (2001) The Transfer of Drugs and Other Chemicals into Human Milk. Pediatrics 108(3):776–789
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Patton, K.K., Page, R.L. (2011). Arrhythmias in Pregnancy and Postpartum. In: Yan, GX., Kowey, P. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-161-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-161-5_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-160-8
Online ISBN: 978-1-60761-161-5
eBook Packages: MedicineMedicine (R0)